Multiple Ascending Oral Dose Phase I Study With Px-102
NCT01998672
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Px-102
DRUG:
Placebo
Sponsor
Phenex Pharmaceuticals AG